论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Dupilumab 成功治疗银屑病合并大疱性类天疱疮:一病例报告
Authors Liu JH, Gao Q , Ma WY , Cheng ZL, Luo NN , Hao PS
Received 30 March 2023
Accepted for publication 31 May 2023
Published 20 June 2023 Volume 2023:16 Pages 1583—1587
DOI https://doi.org/10.2147/CCID.S415019
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr Jeffrey Weinberg
Abstract: Psoriasis is an immune-mediated chronic inflammatory disease that can be combined with complications such as diabetes, cardiovascular disease, obesity, and kidney disease. The comorbidity of psoriasis with autoimmune bullous diseases (AIBD) has been reported previously in several cases, the most frequent of which is bullous pemphigoid (BP). The underlying mechanisms of psoriasis with BP are not clear and there are no uniform treatment criteria. Based on previous case reports, the coexistence of psoriasis and BP may be related to inflammatory activity, medications, phototherapy, and infection. We report a case of a psoriasis patient who developed BP after taking Chinese herbal compounds and was successfully treated with dupilumab, which is the first reported case of applying dupilumab to treat psoriasis with BP comorbidities.
Keywords: autoimmune bullous diseases, dupilumab, biologics, comorbidity, Chinese herbal compounds